Prevalence and Relationship Between Diabetic Retinopathy and Nephropathy, and its Risk Factors in the North-East of Spain, a Population-Based Study

REFERENCES

• King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414–1431.
   PubMed Web of Science ®Google Scholar
• The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2000). Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 23:S4–S19.
   Google Scholar
• Geiss L, Engelgau M, Fraizer E, Tierney E. Diabetes surveillance, 1997. Centers for Disease Control and Prevention. U.S. Department of Health and Human Services Atlanta GA. 1997.
   Google Scholar
• Diabetes Control and Complications trial/Epidemiology of Diabetes Interventions and Complications Research Group. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus. Arch Ophthalmology. 2008;126(12):1707–1715.
   PubMedGoogle Scholar
• Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Turner RC. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol. 1998;116(3):297–303.
   PubMedGoogle Scholar
• Consell Assesor sobre Diabetes a Catalunya. Registre de diabetes tipus 1 de Catalunya, 1995–2002. Butlleti Epidemiològic de Catalunya. Vol XXIII, num 4. Barcelona. Departament de Sanitat i Seguretat Social, 2002.
   Google Scholar
• Castell C, Tresserras R, Lloveras G, Goday A, Serra J, Salleras L. Prevalence of diabetes in Catalonia, an OGTT-based population study. Diab Res Clin Prac. 1999;43(1):33–40.
   PubMedGoogle Scholar
• Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK. Methodology for retinal photography and assessment of diabetic retinopathy, The EURODIAB IDDM complications study. Diabetologia. 1995;38(4):437–444.
   PubMedGoogle Scholar
• Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Kampik A, Pararajasegaram R, Verdaguer JT; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677–1682.
   PubMedGoogle Scholar
• ETDRS. Detection of diabetic macular edema study n°5. Ophthalmology. 1989;96:746–751.
   PubMedGoogle Scholar
• The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and treatment of High Blood Pressure. Arch Intern Med. 1997;157(21):2413–2442.
   PubMedGoogle Scholar
• American Diabetes Association. Clinical practice recommendations. Diabetes Care. 2002;25, suppl 1.
   Google Scholar
• European Diabetes Policy Group. A Desktop guide to type I (insulin-dependent) diabetes mellitus 1998–199. Guidelines for diabetes care. Diabetic Med. 1999; 16(3):253–266.
   PubMedGoogle Scholar
• American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1201.
   PubMed Web of Science ®Google Scholar
• Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease, with emphasis on the stage of incipient diabetic nephropathy. Diabetes. 1983;32 Suppl 2:64–78.
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection, Evaluation, And Treatment of high Blood Cholesterol in Adults (Adult Treatment Panel III). Executive summary of the third report of the National Cholesterol Education Program (NCEP). JAMA. 2001;285:2486–2497.
   PubMed Web of Science ®Google Scholar
• Rifai N, Ridker PM. Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem. 2001;47(1):28–30.
   PubMedGoogle Scholar
• Romero-Aroca P, del Castillo-Déjardin D. Estudio de prevalencia de retinopatía diabética en la población del Baix Camp (Tarragona). Arch Soc Esp Oftalmol. 1996;71:261–268.
   Google Scholar
• López IM, Díez A, Velilla S, Rueda A, Alvarez A, Pastor CJ. Prevalence of diabetic retinopathy and eye care in a rural area of Spain. Ophthalmic Epidemiol. 2002;9(3):205–214.
   PubMedGoogle Scholar
• Santos-Bueso E, Fernández-Vigo J, Fernández-Pérez C, Macarro-Merino A, Fernández-Perianes J. Prevalencia de retinopatía diabética en la Comunidad Autónoma de Extremadura. 1997–2001 (Proyecto Extremadura para prevención de la ceguera). Arch Soc Esp Oftalmol. 2005;80(3):187–194.
   PubMedGoogle Scholar
• Teruel-Macias C, Fernández-Real JM, Ricart W, Valent-Ferrer R, Vallés-Prats M.Prevalencia de la retinopatía diabética en la población de diabéticos diagnosticados en las comarcas de Girona. Estudio de los factores asociados. Arch Soc Esp Oftalmol. 2005;80(3):85–91
   PubMedGoogle Scholar
• Davis TM, Stratton IM, Fox CJ, Holman RR, Turner RC. UK Prospective Diabetes Study 22. Effect of age at diagnosis on diabetic tissue damage during the first 6 years of NIDDM. Diabetes Care. 1997;20 (9):1435–1441.
   PubMedGoogle Scholar
• Lundman B, Engstrom L. Diabetes and it’s complications in a Swedish county. Diabetes Res Clin Pract. 1998;39 (2):157–164.
   PubMedGoogle Scholar
• Toeller M, Buyken AE, Heitkamp G, Berg G, Scherbaum WA.Prevalence of chronic complications, metabolic control and nutritional intake in type I diabetes: comparison between different European regions. EURODIAB Complications Study group. Horm Metab Res. 1999;31:680–685.
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology. 1998;105(10):1801–1815.
   PubMedGoogle Scholar
• Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology. 1989;96(10):1501–1510.
   PubMedGoogle Scholar
• Klein BE, Moss SE, Klein R, Surawicz TS: The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology. 1991;98:1261–1265.
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Moss SE. Is serum cholesterol associated with progression of diabetic retinopathy or macular edema in persons with younger onset diabetes of long duration? Am J Ophthalmol. 1999;128(5):652– 654.
   PubMedGoogle Scholar
• Chew EY, Klein ML, Ferris FL 3rd, Remaley NA, Murphy RP, Chantry K, Hoogwerf BJ, Miller D. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy: Early Treatment Diabetic Retinopathy Study (ETDRS) report 22. Arch Ophthalmol. 1996;114(9):1079 –1084.
   PubMedGoogle Scholar
• Millán J, Pintó X, Muñoz A, et al. Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention. Vasc Health Risk Manag. 2009;5:757–65.
   PubMedGoogle Scholar
• Mohan R, Mohan V, Susheela L, Ramachandran A, Viswanathan M. Increased LDL cholesterol in non-insulin-dependent diabetics with maculopathy. Acta Diabetol Lat. 1984;21(1):85–89.
   PubMedGoogle Scholar
• Landmesser U, Hornig B, Drexler H. Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. Semin Thromb Hemost. 2000;26(5):529 –537.
   PubMedGoogle Scholar
• Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell SE, Adamis AP. Leukocyte mediated endothelial cell injury and death in the diabetic retina. Am J Pathol. 2001;158(1):147–152.
   PubMedGoogle Scholar
• Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J. 2002;16(3):438–440.
   PubMedGoogle Scholar
• Brancati FL, Cusumano AM. Epidemiology and prevention of diabetic nephropathy. Current Opinion in Nephrolology and Hypertension. 1995;4(3):223–229.
   PubMedGoogle Scholar
• Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin N Am. 2004;88(4):1001–1036.
   PubMedGoogle Scholar
• Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care. 2003;26(4):1258–1264.
   PubMedGoogle Scholar
• Rossi MC, Nicolucci A, Pellegrini F, et al. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of Renal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant. 2008;23(4):1278–1284.
   PubMedGoogle Scholar
• Skrivarhaug T, Bangstad HJ, Stene LC, Sandvik L, Hanssen KF, Joner G. Low risk of overt nephropathy after 24 yr of childhood-onset type 1 diabetes mellitus (T1DM) in Norway. Pediatr Diabetes. 2006;7(5):239–246.
   PubMedGoogle Scholar
• Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes. 2006;55(5):1463–1469.
   PubMedGoogle Scholar